Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 18 clinical trials
Featured trial
Study of Lademirsen (SAR339375) in Patients With Alport Syndrome (HERA)

Primary Objectives: To assess the efficacy of lademirsen (SAR339375) in reducing the decline in renal function To assess the safety and tolerability of lademirsen (SAR339375) in subjects with Alport syndrome Secondary Objectives: To assess plasma pharmacokinetic (PK) parameters of the parent compound and its metabolites To assess the potential formation …

  • 0 views
  • 23 Nov, 2021
  • 23 locations
DUR-928 in Subjects With SARS-CoV-2 With Acute Liver or Kidney Injury

Evaluate safety and efficacy of DUR-928 in treatment of acute organ failure in subjects infected with SARS-CoV-2

SARS
kidney injury
acute respiratory syndrome (sars)
liver disease
organ failure
  • 0 views
  • 01 Feb, 2023
KDIGO Bundle to Prevent AKI in Sepsis

Summary: Controlled, prospective, randomized and randomized clinical trial of two intervention groups (standard care vs. preventive recommendations the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for AKI) of patients diagnosed with sepsis and abdominal post-surgical septic shock with positive results in the risk determination of acute renal injury by NephroCheck …

  • 0 views
  • 16 Feb, 2024
  • 1 location
Extracorporeal Blood Purification as a Treatment Modality for COVID-19

Several studies have suggested a potential clinical benefit of controlling hyper inflammation triggered by SARS-CoV-2/COVID-19. Blood purification, the removal of excessive proinflammatory mediators may control disease progression and support clinical recovery. For this purpose, COVID-19 patients might benefit from treatment with AN69ST hemofilter based extracorporeal blood purification.

pneumonia
x-rays
SARS
ct scan
acute respiratory syndrome (sars)
  • 0 views
  • 16 Feb, 2024
  • 1 location
Liberation From Acute Dialysis

The goal of the LIBERATE-D clinical trial is to improve outcomes for patients recovering from dialysis-requiring acute kidney injury (AKI-D). The impact of a conservative dialysis strategy compared to standard clinical practice of thrice-weekly dialysis will be examined to help generate knowledge for how to guide delivery of dialysis to …

liberate
renal injury
glomerular filtration rate
acute renal failure
vasopressor
  • 0 views
  • 16 Feb, 2024
  • 2 locations
Study of Lademirsen (SAR339375) in Patients With Alport Syndrome (HERA)

Primary Objectives: To assess the efficacy of lademirsen (SAR339375) in reducing the decline in renal function To assess the safety and tolerability of lademirsen (SAR339375) in subjects with Alport syndrome Secondary Objectives: To assess plasma pharmacokinetic (PK) parameters of the parent compound and its metabolites To assess the potential formation …

  • 0 views
  • 23 Nov, 2021
Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function

Whether replacement of tacrolimus by Everolimus preserves kidney function in patients with pre-existing chronic kidney disease or acute kidney injury is not well established. Also, the efficacy and safety of reduced-dose Everolimus with or without Mycophenolate Mofetil in prevention of rejection is unknown.

anti-thymocyte globulin
rabbit atg
liver transplant
glomerular filtration rate
acute renal failure
  • 0 views
  • 16 Feb, 2024
  • 1 location
Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI

The secondary endpoint will comprise a composite of device success, early safety and clinical efficacy as defined by the Valve Academic Research Consortium-2 (VARC-2)(1) and will comprise death, vascular complications, stroke/ Transient Ischemic Attack (TIA), life threatening bleeding requiring transfusion, and acute kidney injury requiring dialysis.

angina
vascular complications
stenosis
acute renal failure
syncope
  • 0 views
  • 16 Feb, 2024
  • 1 location
Biomarkers of Acute Kidney Injury Following Cardiac Surgery

Acute kidney injury occurs in up to 30% of patients undergoing cardiac surgery. Cardiac surgery associated-acute kidney injury (CSA-AKI) is characterized by a sudden and sustained decrease in renal function with insufficient elimination waste products.

  • 0 views
  • 05 Aug, 2020
Clinical Application of Quantitative Ultrasonographic Analysis in Early Kidney Injury  

The purpose of this study was to quantify overall blood flow and renal cortical perfusion in patients with septic acute kidney injury (AKI) using ultrasound (US) Doppler and contrast-enhanced ultrasound (CEUS).

  • 0 views
  • 11 Jan, 2023
  • 1 location